Hologic today announced that it acquired molecular diagnostic company Diagenode for $159 million. Through the deal, Hologic will pay $159 million, subject to working capital and other customary closing adjustments. European Diagenode develops molecular diagnostic assays and epigenetic products. It has more than 30 real-time PCR tests that are CE-marked to detect bacteria, parasites and […]
Mergers & Acquisitions
Thermo Fisher completes Mesa Biotech acquisition
Thermo Fisher Scientific (NYSE:TMO) announced today that it completed its previously announced acquisition of Mesa Biotech. Last month, Waltham, Mass.-based Thermo Fisher announced its agreement to buy the point-of-care molecular diagnostic developer for approximately $450 million in cash. Mesa Biotech will become part of Thermo Fisher’s life sciences solution segment and is expected to bring […]
Terumo to acquire Health Outcomes Sciences
Terumo (TSE: 4543) recently announced that it has signed a definitive agreement to acquire all assets of Health Outcomes Sciences. The financial terms of the deal were not disclosed. Phoenix-based HOS is a creator of predictive analytics and clinical decision support software. Its sePRISM content enablement platform is meant to enable healthcare organizations to deliver […]
Axonics acquires Contura and its Bulkamid bulking agent for $235M
Axonics (NSDQ: AXNX) announced today that it acquired Contura and its flagship Bulkamid product for up to $235 million. London-based Contura’s Bulkamid is a urethral bulking agent for women with stress urinary incontinence (SUI). It is a next-generation hydrogel injected into the urethral wall in a minimally invasive office or outpatient facility procedure to restore the natural […]
NuVasive acquires Simplify Medical in $150M deal
NuVasive (NSDQ:NUVA) yesterday announced that it has acquired Simplify Medical for $150 million. Through the deal, NuVasive made an upfront payment of $150 million at closing using cash on hand, subject to customary purchase price adjustments. The company agreed to make additional future payments contingent upon milestones related to regulatory approval and net sales. Simplify Medical […]
Hologic completes Biotheranostics acquisition
Hologic (NSDQ:HOLX) announced that it completed its previously announced acquisition of Biotheranostics for $230 million. Marlborough, Mass.-based Hologic last month announced that it was set to buy Biotheranostics and its two molecular diagnostic tests for breast and metastatic cancers, the Breast Cancer Index and CancerTYPE ID. Both laboratory-developed tests are not required to be cleared by […]
PavMed to spin off subsidiary Lucid Diagnostics
Pavmed (NSDQ:PAVM) announced today that its majority-owned subsidiary Lucid Diagnostics will spin off into a separate public company. In a news release, Pavmed said Lucid Diagnostics intends to spin off if favorable market conditions continue to hold, whether it be through an initial public offering (IPO) or a business combination with a healthcare special purpose acquisition corporation. […]
MedTech 100 roundup: Slight dip after all-time best for industry
The medtech industry’s stocks rose higher than they ever had to begin last week before eventually dropping to a slightly more normal level. MassDevice‘s MedTech 100 index ended the week (Feb. 19) at 108.72 points, marking a -1.7% dip from the 110.63-point mark set at the end of the previous week (Feb. 12). On Monday (Feb. […]
Butterfly Network completes merger, starts trading on NYSE
Butterfly Network (NYSE:BFLY) announced today that it completed its merger with Longview Acquisition Corp. and is now trading on the NYSE. Last week, Longview announced that its stockholders had approved the business combination, from which Butterfly received approximately $859 million before transaction fees, including $414 million held in Longview’s trust account and $175 million from […]
MedTech 100 roundup: Rise to new heights continues
The medtech industry hit another high as 2021 continues to bring strong performances out of some of the biggest companies around. MassDevice‘s MedTech 100 index ended the week (Feb. 12) at 110.63 points, marking a 2.2% rise from the 108.23-point mark set at the end of the previous week (Feb. 5). The final mark for the […]
Butterfly Network to start trading on NYSE soon
Longview Acquisition Corp. announced today that its stockholders approved its merger with Butterfly Network, which will soon begin trading on the New York Stock Exchange. Stockholders approved the business combination with nearly 100% of the shares of Longview voted at a special meeting in favor of the merger, with a total of six proposals considered […]
